Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.8000 (5.02%) ($6.8000 - $6.8000) on Tue. May. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.15% (three month average) | RSI | 55 | Latest Price | $6.8000(5.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.1% a day on average for past five trading days. | Weekly Trend | TGTX declines -5.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(71%) IBB(68%) ARKK(65%) IBUY(59%) | Factors Impacting TGTX price | TGTX will decline at least -3.075% in a week (0% probabilities). VIXM(-54%) VXX(-39%) UUP(-19%) TBT(-10%) USO(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.075% (StdDev 6.15%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.88(-230.59%) | Resistance Level | $6.9 | 5 Day Moving Average | $6.3(7.94%) | 10 Day Moving Average | $6.66(2.1%) | 20 Day Moving Average | $6.9(-1.45%) | To recent high | -37% | To recent low | 19.4% | Market Cap | $861m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |